IP Library Granted Patent US 11,154,492
Granted Patent B2
US 11,154,492 · App. 16/070,391 · Granted Oct 26, 2021

Bioactive compositions from ginseng plant (

Inventors: Michael Koganov (White Plains, NY); Olga Dueva-Koganov (White Plains, NY); Paul Recht (Pleasantville, NY); Artyom Duev (White Plains, NY); Li Zhang (Princeton, NJ); Steven Micceri (Milford, CT); Robert Turner (Peekskill, NY)
Assignee: ISP INVESTMENTS LLC
A61K8/9789A61K36/258A61Q19/00A61K2800/74A61K2800/75A61Q19/005A61Q19/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,154,492
App. No.
16/070,391
Granted
Oct 26, 2021
Kind
B2
Abstract

The present invention relates to bioactive compositions (including, for example, bioactive serum fractions and bioactive extracts) derived from ginseng ( Panax spp.) fresh whole plant, a particular part of the plant (e.g., rhizome, roots, leaves, stems, flowers, fruit) or any combination of these plant parts. The bioactive serum fractions and bioactive extracts are free of or substantially free of pulegone and/or free of or substantially free of proteins. The present invention also provides products comprising the bioactive serum fractions and/or bioactive extracts. The present invention further provides methods of making and using the bioactive serum fractions and/or bioactive extracts. Further, the bioactive serum fractions and bioactive extracts have anti-inflammatory and/or anti-irritant and/or anti-aging activities.

Claims (15)

1. A bioactive serum fraction derived from a ginseng ( Panax spp.) plant, wherein said bioactive serum fraction comprises:

(i) a total pulegone content of less than 100 ppm,

(ii) a total protein content of less than 0.675 wt %, and

wherein the said bioactive serum fraction further comprises. a combination of preservatives and stabilizers consisting of a sodium metabisulfite content of 0.20 wt %, potassium sorbate content of 0.10 wt %, sodium benzoate content of 0.10 wt %, tetrasodium EDTA content of 0.25 wt % and pentylene glycol content of 1.90 wt %, by weight of the total composition, and

wherein the said bioactive serum fraction comprises bioactive properties selected from the group consisting of anti-oxidant activity, anti-inflammatory activity, anti-aging activity, and anti-irritant activity.

2. The bioactive serum fraction according to claim 1 , wherein the bioactive serum fraction is derived from the whole ginseng plant, a part of the ginseng plant, or a combination of different parts of the ginseng plant.

3. The bioactive serum fraction according to claim 2 , wherein the part of the ginseng plant is selected from the group consisting of rhizome, roots, leaves, stems, flowers, and fruit.

4. The bioactive serum fraction according to claim 1 , wherein said serum fraction comprises a total pulegone content of less than 25 ppm.

5. The bioactive serum fraction according to claim 1 , wherein said serum fraction comprises a total protein content of less than 0.500 wt %.

6. A product comprising a bioactive serum fraction according to claim 1 .

7. The product according to claim 6 , wherein said product comprises a leave-on product selected from the group consisting of a cream, a dressing, a gel, a lotion, an ointment, a liquid, a spray applicator, and combinations thereof, or a wash-off product selected from the group consisting of hand dishwashing detergent, liquid hand soap, bar soap, body wash, shampoo, general purpose cleanser, and combinations thereof.

8. The product according to claim 6 , wherein said product comprises a functional food or a functional beverage.

9. The product according to claim 6 , wherein said product comprises a nutraceutical.

10. A method of using a product comprising the bioactive serum fraction according to claim 1 , said method comprising:

administering the product to a subject under conditions effective to provide anti-inflammatory, anti-irritant, and/or anti-aging activity to the subject.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Jan 10, 2020
From: THE BANK OF NOVA SCOTIA
To: HERCULES LLC; ISP INVESTMENTS LLC
Reel/Frame 051561/0676 →
SUPPLEMENTAL SECURITY AGREEMENT Recorded May 24, 2019
From: HERCULES LLC; ISP INVESTMENTS LLC
To: THE BANK OF NOVA SCOTIA
Reel/Frame 049286/0434 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 16, 2018
From: KOGANOV, MICHAEL; DUEVA-KOGANOV, OLGA; RECHT, PAUL; DUEV, ARYTOM; ZHANG, LI; MICCERI, STEVEN; TURNER, ROBERT
To: ISP INVESTMENTS LLC
Reel/Frame 046359/0119 →